MEDLINE INC. CLASS A COMMON STOCK

NASDAQ: MDLN (Medline Inc.)

Kemas kini terakhir: 20 jam lalu

32.00

-0.37 (-1.14%)

Penutupan Terdahulu 32.37
Jumlah Dagangan 15,890,048
Harga / Pendapatan (P/E Ke hadapan) 19.75
Harga / Jualan (P/S) 1.44
Harga / Buku (P/B) 2.45
Julat 52 Minggu
31.49 (-1%) — 50.88 (58%)

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Medical Instruments & Supplies (US) Bercampur Bercampur
Medical Instruments & Supplies (Global) Bercampur Bercampur
Stok Medline Inc. Bercampur -

AISkor Stockmoo

0.4
Konsensus Penganalisis 0.0
Aktiviti Orang Dalam NA
Volatiliti Harga 2.5
Purata Bergerak Teknikal 0.0
Osilator Teknikal -0.5
Penilaian Relatif NA
Kesihatan Kewangan NA
Persekitaran Makro -0.3
AI Insight NA
AI Technical NA
Purata 0.35

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
MDLN - - - 2.45
ISRG 151 B - 48.93 7.82
ALGN 11 B - 26.34 2.49
NEPH - - - 3.19
PDEX - - - 4.12
MBOT - - - 1.09

Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.

Sektor Healthcare
Industri Medical Instruments & Supplies
Gaya Pelaburan Mid Growth

Tiada data dalam julat masa ini.

Tiada data dalam julat masa ini.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2026 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda